Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.
NCT ID: NCT00796393
Last Updated: 2011-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2008-11-30
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics (L. Gasseri, B. Bifidum, B. Longum) on Immune and Intestinal Health in Healthy Older Adults
NCT01662206
Effect of a Mixture of Probiotics on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adults
NCT01652066
Probiotics in Prevention of Common Cold
NCT02013934
Analysis of the Gut Microbiota Composition After Consumption of Probiotic Bacteria
NCT07046897
Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections
NCT00599430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2
Subject with active product, not vaccinated against influenza.
Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033
1 pill per day for 12 weeks
3
Subject with placebo, vaccinated against influenza.
Starch of potato
1 pill per day for 12 weeks
4
Subject with placebo, not vaccinated against influenza.
Starch of potato
1 pill per day for 12 weeks
1
Subject with active product, vaccinated against influenza
Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033
1 pill per day for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033
1 pill per day for 12 weeks
Starch of potato
1 pill per day for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Regular consumption of probiotics
* Diabetes
* Respiratory deficiency
* Cardiac deficiency
* Cancer or chronicle disease not stabilized
* Splenectomy, sickle-cell anemia
* Immuno depression or immunodeficiency acquired or congenital
* Immuno depressor or corticoid treatments
60 Years
74 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioFortis
OTHER
Institut Rosell Lallemand
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Institut Rosell Lallemand
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Marc Cazaubiel, Dr
Role: PRINCIPAL_INVESTIGATOR
BioFortis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biofortis
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-A01187-48
Identifier Type: -
Identifier Source: secondary_id
10308
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.